These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26639242)

  • 21. Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine.
    Cheng L; Sun X; Scicluna BJ; Coleman BM; Hill AF
    Kidney Int; 2014 Aug; 86(2):433-44. PubMed ID: 24352158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential of mid-infrared spectroscopy as a non-invasive diagnostic test in urine for endometrial or ovarian cancer.
    Paraskevaidi M; Morais CLM; Lima KMG; Ashton KM; Stringfellow HF; Martin-Hirsch PL; Martin FL
    Analyst; 2018 Jun; 143(13):3156-3163. PubMed ID: 29878018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types.
    Kobayashi M; Sawada K; Nakamura K; Yoshimura A; Miyamoto M; Shimizu A; Ishida K; Nakatsuka E; Kodama M; Hashimoto K; Mabuchi S; Kimura T
    J Ovarian Res; 2018 Sep; 11(1):81. PubMed ID: 30219071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer.
    Hanžek A; Siatka C; Duc AE
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7981-7993. PubMed ID: 36914786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of miR-16 as an endogenous reference gene for the normalization of urinary exosomal miRNA expression data from CKD patients.
    Lange T; Stracke S; Rettig R; Lendeckel U; Kuhn J; Schlüter R; Rippe V; Endlich K; Endlich N
    PLoS One; 2017; 12(8):e0183435. PubMed ID: 28859135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the miR-200 family in tumor tissue, plasma and urine of epithelial ovarian cancer patients in comparison to benign counterparts.
    Savolainen K; Scaravilli M; Ilvesmäki A; Staff S; Tolonen T; Mäenpää JU; Visakorpi T; Auranen A
    BMC Res Notes; 2020 Jul; 13(1):311. PubMed ID: 32611374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of microRNA in urine to identify patients with endometrial cancer: a feasibility study.
    Donkers H; Hirschfeld M; Weiß D; Erbes T; Jäger M; Pijnenborg J; Bekkers R; Galaal K
    Int J Gynecol Cancer; 2021 Jun; 31(6):868-874. PubMed ID: 33911004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of microRNAs in the urine of patients with bladder cancer.
    Wang G; Chan ES; Kwan BC; Li PK; Yip SK; Szeto CC; Ng CF
    Clin Genitourin Cancer; 2012 Jun; 10(2):106-13. PubMed ID: 22386240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study.
    Ruan L; Xie Y; Liu F; Chen X
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():31-38. PubMed ID: 29353130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitro.
    Hirschfeld M; Ge I; Rücker G; Waldschmidt J; Mayer S; Jäger M; Voigt M; Kammerer B; Nöthling C; Berner K; Weiss D; Asberger J; Erbes T
    Mol Med Rep; 2020 Nov; 22(5):4048-4060. PubMed ID: 33000259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA and gynecologic cancers.
    Kanekura K; Nishi H; Isaka K; Kuroda M
    J Obstet Gynaecol Res; 2016 Jun; 42(6):612-7. PubMed ID: 27098274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between cellular and exosomal miRNAs targeting NOD-like receptors in bladder cancer: preliminary results.
    Poli G; Egidi MG; Cochetti G; Brancorsini S; Mearini E
    Minerva Urol Nefrol; 2020 Apr; 72(2):207-213. PubMed ID: 31144487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patients.
    Chung YW; Bae HS; Song JY; Lee JK; Lee NW; Kim T; Lee KW
    Int J Gynecol Cancer; 2013 May; 23(4):673-9. PubMed ID: 23542579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Verification of microRNA expression in human endometrial adenocarcinoma.
    Jurcevic S; Klinga-Levan K; Olsson B; Ejeskär K
    BMC Cancer; 2016 Apr; 16():261. PubMed ID: 27039384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study.
    Ramezani A; Devaney JM; Cohen S; Wing MR; Scott R; Knoblach S; Singhal R; Howard L; Kopp JB; Raj DS
    Eur J Clin Invest; 2015 Apr; 45(4):394-404. PubMed ID: 25682967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beyond circulating microRNA biomarkers: Urinary microRNAs in ovarian and breast cancer.
    Gasparri ML; Casorelli A; Bardhi E; Besharat AR; Savone D; Ruscito I; Farooqi AA; Papadia A; Mueller MD; Ferretti E; Benedetti Panici P
    Tumour Biol; 2017 May; 39(5):1010428317695525. PubMed ID: 28459207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA expression profiling in endometriosis-associated infertility and its relationship with endometrial receptivity evaluated by ultrasound.
    Xu X; Li Z; Liu J; Yu S; Wei Z
    J Xray Sci Technol; 2017; 25(3):523-532. PubMed ID: 28506024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A PEG-based method for the isolation of urinary exosomes and its application in renal fibrosis diagnostics using cargo miR-29c and miR-21 analysis.
    Lv CY; Ding WJ; Wang YL; Zhao ZY; Li JH; Chen Y; Lv J
    Int Urol Nephrol; 2018 May; 50(5):973-982. PubMed ID: 29330775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential microRNA expression by Solexa sequencing in the sera of ovarian cancer patients.
    Ji T; Zheng ZG; Wang FM; Xu LJ; Li LF; Cheng QH; Guo JF; Ding XF
    Asian Pac J Cancer Prev; 2014; 15(4):1739-43. PubMed ID: 24641401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer.
    Tölle A; Jung M; Rabenhorst S; Kilic E; Jung K; Weikert S
    Oncol Rep; 2013 Oct; 30(4):1949-56. PubMed ID: 23877086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.